Ghotbi Elena, Bluemke David A, Hathaway Quincy A, Klein Joshua G, Shabani Mahsima, Akhtarkhavari Sepehr, Barr R Graham, Bancks Michael P, Post Wendy S, Budoff Matthew, Lima João A C, Demehri Shadpour
Department of Radiology and Radiologic Sciences, Johns Hopkins University, Baltimore, MD, USA.
Department of Radiology, University of Wisconsin-Madison School of Medicine and Public Health, Madison, WI, USA.
Eur Radiol. 2025 Aug 9. doi: 10.1007/s00330-025-11778-9.
To evaluate the discriminative power of coronary artery calcium (CAC) score-based Cox models for predicting cardiovascular disease (CVD) in older adults with longstanding diabetes, a population at elevated CVD risk. We also aimed to determine whether adding computed tomography (CT)-derived costal cartilage calcification (CCC) improves risk prediction, given the potential limitation of CAC due to widespread soft tissue calcification.
We analyzed adults ≥ 65 years from the multi-ethnic study of atherosclerosis with longstanding diabetes mellitus (DM, ≥ 5 years, n = 231) and compared them to non-DM participants (n = 1148). We evaluated CAC-based risk models (adjusted for Framingham Risk Score, race/ethnicity, and statin use) and assessed the impact of adding CCC on model performance using Cox proportional-hazards regression and Harrell's C-statistic to predict CVD and coronary heart disease (CHD) incidence. CHD events included fatal coronary events, resuscitated cardiac arrest, myocardial infarction, adjudicated angina, and revascularization with angina. CVD events encompassed CHD, stroke (excluding transient ischemic attack), cardiovascular death, or other atherosclerotic deaths.
Over 8.7 years, CVD and CHD events occurred in 17% and 10% of DM participants and 11% and 5% of non-DM participants, respectively. In longstanding DM participants, doubling of CAC was associated with higher CVD risk (HR: 1.13; 95% CI: 1.01-1.26), with model discrimination improving from C-statistic 0.66 to 0.69 (p = 0.02) after adding CCC. For CHD, the corresponding HR was 1.05 (95% CI: 0.98-1.13), and the C-statistic rose from 0.65 to 0.69 (p = 0.04). In non-DM participants, CCC did not enhance model performance for either CVD or CHD (p > 0.5).
CCC, a measurable biomarker of non-cardiovascular calcification from any conventional CT, improves CVD and CHD risk prediction models' performance in older adults with longstanding DM.
Question Coronary artery calcium (CAC) may have limited discriminative power for predicting cardiovascular outcomes in older adults with longstanding diabetes. Findings Costal cartilage calcification (CCC), a biomarker of non-cardiovascular calcification from CT, improves the prediction of cardiovascular disease and coronary heart disease risks in this population. Clinical relevance Incorporating CCC, which can be easily measured using existing CAC assessment tools on CT scans, into cardiovascular risk assessment could refine clinical decision-making and improve individualized risk stratification in older adults with longstanding diabetes.
评估基于冠状动脉钙化(CAC)评分的Cox模型对长期糖尿病老年患者心血管疾病(CVD)的预测能力,该人群心血管疾病风险较高。鉴于广泛软组织钙化导致CAC存在潜在局限性,我们还旨在确定添加计算机断层扫描(CT)衍生的肋软骨钙化(CCC)是否能改善风险预测。
我们分析了来自动脉粥样硬化多民族研究的65岁及以上患有长期糖尿病(DM,≥5年,n = 231)的成年人,并将他们与非糖尿病参与者(n = 1148)进行比较。我们评估了基于CAC的风险模型(根据弗雷明汉风险评分、种族/民族和他汀类药物使用情况进行调整),并使用Cox比例风险回归和Harrell's C统计量来预测CVD和冠心病(CHD)发病率,评估添加CCC对模型性能的影响。CHD事件包括致命性冠状动脉事件、心肺复苏成功的心脏骤停、心肌梗死、确诊的心绞痛以及伴有心绞痛的血运重建。CVD事件包括CHD、中风(不包括短暂性脑缺血发作)、心血管死亡或其他动脉粥样硬化性死亡。
在8.7年的时间里,DM参与者中17%发生了CVD事件,10%发生了CHD事件;非DM参与者中分别为11%和5%。在长期DM参与者中,CAC翻倍与更高的CVD风险相关(HR:1.13;95%CI:1.01 - 1.26),添加CCC后模型判别能力从C统计量0.66提高到0.69(p = 0.02)。对于CHD,相应的HR为1.05(95%CI:0.98 - 1.13),C统计量从0.65提高到0.69(p = 0.04)。在非DM参与者中,CCC并未提高CVD或CHD的模型性能(p > 0.5)。
CCC是任何传统CT检查中可测量的非心血管钙化生物标志物,可改善长期DM老年患者的CVD和CHD风险预测模型的性能。
问题冠状动脉钙化(CAC)在预测长期糖尿病老年患者心血管结局方面的判别能力可能有限。发现肋软骨钙化(CCC)是一种来自CT的非心血管钙化生物标志物,可改善该人群心血管疾病和冠心病风险的预测。临床意义将CCC纳入心血管风险评估中,可利用CT扫描现有的CAC评估工具轻松测量,这可能会优化临床决策,并改善长期糖尿病老年患者的个体化风险分层。